Showing results (11-20 of 616) with videos related to
Sort By:
Pageof 62
The Journal of Rheumatology|April 1, 1992
Cyclosporine nephrotoxicity in rheumatoid arthritis: no effect of short term misoprostol treatmentM Boers, W G Bensen, D Ludwin, et al.The Journal of Rheumatology|March 25, 1999
Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trialsB Pham, A Cranney, M Boers, et al.The Journal of Rheumatology|January 26, 1999
The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trialsZ Ortiz, B Shea, M Garcia Dieguez, et al.The Journal of Rheumatology|January 26, 1999
Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for RheumatologyG Wells, M Boers, B Shea, et al.The Journal of Rheumatology|March 15, 2001
Minimal clinically important differences: review of methodsG Wells, D Beaton, B Shea, et al.The Journal of Rheumatology|January 26, 1999
Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in RheumatologyM Gazarian, P Tugwell, M Boers, et al.The Journal of Rheumatology|July 1, 1995
Interactive conference voting. The OMERACT II Committee. Outcome Measures in Rheumatoid Arthritis Clinical Trial ConferenceC H Goldsmith, E Duku, P M Brooks, et al.Seminars in Arthritis and Rheumatism|June 1, 1992
Cyclosporine in rheumatoid arthritis: documented efficacy and safetyP TugwellThe Journal of Rheumatology. Supplement|March 1, 1996
Combination therapy in rheumatoid arthritis: metaanalysisP TugwellPageof 62